Research News and Research

RSS

Different hunger calculation approach could help use resources more effectively

In a New York Times opinion piece, Robert Jensen, an associate professor of public policy at the University of California, Los Angeles, and Nolan Miller, a professor of finance at the University of Illinois at Urbana-Champaign, suggest an alternate strategy for measuring hunger, called the "staple-calorie-share approach," which "can give us a radically different view of who is hungry and who is not."

11 Jul 2011

Cancer Research UK awards £12 million to 10 exceptional researchers

Cancer Research UK has given a number of prestigious grants to new investigators who are set to become the eminent cancer scientists of the future.

11 Jul 2011

RyMed's InVision-Plus Intraluminal Protection System effective against catheter-related bloodstream infections

Denise Macklin, BSN, RNC, representing the research team of Dr. Cynthia C. Chernecky Ph.D., RN, AOCN, FAAN, Dr. Jennifer Waller, Ph.D., both from Georgia Health Sciences University; and Dr. William Jarvis M.D., Jason & Jarvis Associates, exhibited a poster at the recent APIC 2011 (Association for Professionals in Infection Control and Epidemiology) conference in Baltimore, titled "Clinical Comparisons of Split Septum, Positive and Negative Mechanical Valve Intravenous Connectors to an Intraluminal Protection Connector on Infection Rates."

11 Jul 2011

Governors oppose Medicaid cuts in debt-ceiling efforts

One approach being discussed would lower federal payments to states for Medicaid and the CHIP program — which as analysis says would lead to even more budget burdens for already cash-strapped states.

11 Jul 2011

Research validates SpinalCyte's core technology to regrow the spinal disc

SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the publication of its research completed with Rice University, titled, "Chondrogenic Differentiation of Neonatal Human Dermal Fibroblasts Encapsulated in Alginate Beads with Hydrostatic Compression Under Hypoxic Conditions in the Presence of Bone Morphogenetic Protein-2".

11 Jul 2011

Potential causes for drops in children's immunization rate

Childhood immunizations - long proven invaluable in preventing contagious diseases - have become increasingly controversial. Despite numerous studies supporting safety and efficacy, a growing number of parents refuse to vaccinate their children. A study conducted by second-year University of Vermont (UVM) medical students identified several potential causes for drops in Vermont children's immunization rate, which ranks as one of the lowest nationally.

11 Jul 2011

Slow economic recovery slows tally of new health care jobs

Health care employment, which defied the economy by adding jobs through the 2007-09 recession, is looking less robust. The sector is starting to come under pressure as the weak recovery coupled with state budget cuts and uncertainty about the financial effects of the health care overhaul are pushing hospitals and health systems to cut costs.

11 Jul 2011

Fibrin key to protection during gram-negative sepsis

New research from the Trudeau Institute may help to explain why anticoagulant therapies have largely failed to extend the lives of patients with sepsis. The study was led by Deyan Luo, a postdoctoral fellow in Stephen Smiley's laboratory. It shows that fibrin, a key product of the blood clotting process, is critical for host defense against Yersinia enterocolitica, a gram-negative bacterium that causes sepsis in humans and experimental mice.

11 Jul 2011

UNFPA launches 7 Billion Actions campaign

The U.N. Population Fund (UNFPA) on Monday, World Population Day, launched the 7 Billion Actions campaign to "promote dialogue on what it means to live in a world with so many people and encourage action on issues that affect us all.

11 Jul 2011

Sinapis completes first clinical trial of lead drug for stroke and traumatic brain injury

Sinapis Pharma, Inc. is pleased to announce that it has completed its first clinical trial in the development of its lead drug for the treatment of stroke and traumatic brain injury.

11 Jul 2011

Exchange rule likely today

In other health reform coverage, news outlets report on the divisive impact IPAB is having among Democrats, how health care is playing among GOP presidential hopefuls and what might happen in the legal challenge to the health law.

11 Jul 2011

FDA-approved Zuplenz oral soluble film now available for licensing to new commercial partners

MonoSol Rx, a specialty pharmaceutical company and the developers of the PharmFilm technology platform, in collaboration with APR Applied Pharma Research s.a. of Switzerland, announced today that its FDA-approved anti-emetic Zuplenz (Ondansetron) oral soluble film is available for licensing to new commercial partners.

11 Jul 2011

State roundup: Recurring SustiNet rumors in Conn.

The tentative concession deal negotiated between Gov. Dannel P. Malloy's administration and state employee unions is dead. But suspicions it was linked the SustiNet plan to create state-run insurance live on, complicating chances of striking a new deal to avert up to 6,500 layoffs. ... One simple, incontrovertible fact is that there is no SustiNet coverage plan into which state employees can be enticed or forced. But from there, the picture gets fuzzy.

11 Jul 2011

iBio successfully produces human plasma proteins using proprietary technology

iBio, Inc. today announced successful production of human plasma proteins using its proprietary iBioLaunch technology. Human alpha 1-antitrypsin and human C1 esterase inhibitor were successfully produced at high yield in green plants via the Company's proprietary iBioLaunch technology. Both of these proteins are important therapeutic products, but until now they have been made from human blood.

11 Jul 2011

Generex announces convertible preferred stock securities purchase agreement

Generex Biotechnology Corporation today announced that it entered into a securities purchase agreement with certain institutional investors on July 8, 2011.

11 Jul 2011

FDA approves expansion of St. Jude Medical's BROADEN deep brain stimulation study for depression

St. Jude Medical, Inc., a global medical device company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for expansion of its BROADEN (BROdmann Area 25 DEep brain Neurostimulation) study for depression. This expansion will allow a maximum of 20 sites across the U.S. to enroll up to 125 patients.

11 Jul 2011

Sunshine Biopharma completes Adva-27a cytotoxicity study in Multidrug Resistant Breast Cancer cell line

Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.

11 Jul 2011

USANA receives FDA registration to manufacture OTC drugs

USANA Health Sciences, Inc. today announced it has obtained the U.S. Food and Drug Administration's "Drug Establishment Registration," allowing the company to manufacture over-the-counter (OTC) drugs and holding it to a standard well above what is required of a dietary supplement manufacturer.

11 Jul 2011

Scientists study neuronal excitation to treat neurological disorders

Oh, the challenges of being a neuron, responsible for essential things like muscle contraction, gland secretion and sensitivity to touch, sound and light, yet constantly bombarded with signals from here, there and everywhere.

11 Jul 2011

BGI, Covaris partner to provide next generation sequencing technology

BGI and Covaris, Inc. today announced a deal that will integrate Covaris' Adaptive Focused Acoustics AFA DNA shearing technology across several BGI laboratories in China.

11 Jul 2011